ERBB-3 Receptor

Company
Oncogene Sciences, Inc.
Use
Localization, but with limited information, of nuclear ERBB-3 receptor protein
Features
Small inhibitory RNA to ERBB3 or AKT is showing promise as a therapeutic approach to treatment of lung adenocarcinoma.
NIH Contribution
Previous research prompted the designation of the new gene as erbB-3
HHS Institute/Agency
NCI
Inventor(s)
M. Kraus, S. Aaronson
Year
1994
Tech Cat
Research Reagent

Request More Info

L-176-1994